Press Releases Guided Therapeutics, Inc.

Equities

GTHP

US40171F5017

Market Closed - OTC Markets Other stock markets 10:09:39 2024-05-17 am EDT			5-day change	1st Jan Change
0.09 ^USD	-10.00%		-5.26%	-41.37%

May. 14	Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 28	Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results	Feb. 20	BU
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval	Nov. 20	BU
Guided Therapeutics Provides Update on Start of Clinical Trial for US FDA Approval	23-05-01	BU
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-K)	23-03-30	AQ
Guided Therapeutics Announces New Agreement and Purchase Orders from Shandong Yaohua Medical Instrument Corporation	23-03-15	BU
GUIDED THERAPEUTICS INC : Change in Directors or Principal Officers (form 8-K)	23-03-09	AQ
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval	22-12-21	BU
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-14	AQ
Guided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical Scan	22-11-09	BU
GUIDED THERAPEUTICS INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	22-09-15	AQ
Guided Therapeutics Closes $3.3 Million Bridge Financing	22-09-07	BU
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-08-15	AQ
Guided Therapeutics : Modification of Security Holder Rights - Form 8-K	22-07-29	PU
GUIDED THERAPEUTICS INC : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-07-29	AQ
Guided Therapeutics Receives Institutional Review Board Approval to Start Clinical Study for FDA Approval of the LuViva Advanced Cervical Scan	22-07-21	AQ
Guided Therapeutics Receives Institutional Review Board Approval to Start Clinical Study for FDA Approval of the LuViva® Advanced Cervical Scan	22-07-20	BU
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-05-16	AQ
Guided Therapeutics Announces Testing Completion of First 150 Patients in Chinese Clinical Study and Receives Milestone Payment of $177,740	22-03-31	BU
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-K)	22-03-30	AQ
Guided Therapeutics : Modification of Security Holder Rights - Form 8-K	22-01-07	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Guided Therapeutics, Inc.

Equities

GTHP

US40171F5017

Press Releases

Filters